Tag: vertebroplasty

vertebroplasty

Response: The ASBMR taskforce report is “dangerous” and “shameful”

A recent taskforce report charged by the American Society for Bone and Mineral Research (ASBMR) concluded that current evidence does not support the routine...
vertebroplasty

“No further trials of vertebroplasty should be performed”, report concludes

Current evidence does not support the use of vertebroplasty for the treatment of pain from vertebral fractures, concludes a recent task force report charged...

Bone cement solution indicated for treating sacral fractures granted FDA approval

The US Food and Drug Administration (FDA) has granted 510(k) clearance of Kyphon HV-R bone cement (Medtronic) for fixation of pathological fractures of the...

VERTOS IV raises doubts about vertebroplasty

Percutaneous vertebroplasty does not result in statistically significant greater pain relief than a sham procedure, reports a study detailing the results of the VERTOS...

Spinal News International Issue 47 – May 2018

Highlights: Percutaneous vertebroplasty does not result in statistically significant greater pain relief than a sham procedure, according to the most recent results of the...

Percutaneous vertebroplasty and kyphoplasty: current status, new developments and old controversies

Dimitri Filippiadis and Alexis Kelekis (both Department of Radiology II, Attikon University Hospital, Athens, Greece) here detail the history and future of percutaneous vertebroplasty...

IZI Medical Products acquires Cook Medical’s vertebroplasty line

IZI Medical Products has acquired Cook Medical’s vertebroplasty family of devices. The portfolio currently includes Duro-Ject Osteo-Site, Osteo-Force and Vertefix brands, consisting of needles,...

Vertebral augmentation significantly reduces pain in patients with cervical spinal metastases

Rafael De la Garza-Ramos (Monterrey, Mexico, currently resident at Montefiore Medical Center, Bronx, USA) and others report in the International Journal of Spine Surgery...

Vertebroplasty trumps placebo in treatment of painful spinal fractures

On 17 August, a multicentre, randomised, double-blind, placebo-controlled trial—the VAPOUR trial—was published online ahead of print in The Lancet. Six-month data from the trial...